Site Map
Site Map of
http://www.researchandmarkets.com
-
Site Map
-
Pharmaceuticals and Healthcare
-
Pharmaceuticals 1
<< You are in This Category
(
Latest Titles
)
Pharmaceuticals 2
Pharmaceuticals 3
Pharmaceuticals 4
-
Companies
-
Drug Delivery
-
Markets
-
OTC
-
Respiratory
-
Vitamins
-
Drug Discovery
-
Technology
-
E-Healthcare
-
Cardiovascular
-
Central Nervous System
-
Generics
-
Genomics
-
Immune Disorders
-
Infectious Diseases
-
Oncology
-
Pharmacoeconomics
-
Women's Health
-
Fast Facts
-
Analgesics
#
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z
#
Analysis on the Anti-Cold Medicines in the Latest 3 Years
static version
printer friendly
pdf version
Dynamics of Pharmacy Drugs Sales in Russia(March-May 2005) (with Appendix: Russian Pharmaceutical Market Issue: August 2005)
static version
printer friendly
pdf version
Pharmaceutical Anti-Counterfeiting Strategies
static version
printer friendly
pdf version
World Guide to Inflammation Pharma Industry 2005
static version
printer friendly
pdf version
1 Year - U.S. Regulatory Reporter Newsletter for Addresses in Europe
static version
printer friendly
pdf version
1 Year - U.S. Regulatory Reporter Newsletter for International Addresses Outside of Europe
static version
printer friendly
pdf version
1 Year / 2 Year - U.S. Regulatory Reporter Newsletter for Addresses in North America
static version
printer friendly
pdf version
16#
static version
printer friendly
pdf version
2001 Results: Financial Results of the Top 16 Pharmaceutical and Biotechnology Companies
static version
printer friendly
pdf version
2004 HDL CHOLESTEROL - 5th Annual Metabolic Pathways and Drug Targets
static version
printer friendly
pdf version
2005 BioMedical Outsourcing Reports Subscription
static version
printer friendly
pdf version
2005 Chartbook of International Pharmaceutical Prices
static version
printer friendly
pdf version
2005 Global Biopharmaceutical Outsourcing Directory
static version
printer friendly
pdf version
2005 Indian Medical Market Report
static version
printer friendly
pdf version
2005 News in Review: Important Changes for the Pharmaceutical
static version
printer friendly
pdf version
2006 CFR/ICH Good Manufacturing Practice Reference Guide
static version
printer friendly
pdf version
2006 Chartbook of International Pharmaceutical Prices
static version
printer friendly
pdf version
2006 Industry Dynamics: Lessons to Be Learned
static version
printer friendly
pdf version
2007 Chartbook of International Pharmaceutical Prices
static version
printer friendly
pdf version
2007 The Worldwide Biochip & Equipment Market
static version
printer friendly
pdf version
2007 The Worldwide Biochip & Equipment Market
static version
printer friendly
pdf version
2007 Trends to Watch: Pharmaceutical Technology
static version
printer friendly
pdf version
2007 U.S. Community Care Facilities for the Elderly Industry Report
static version
printer friendly
pdf version
2007 U.S. Pharmaceutical Preparation Manufacturing Industry Report
static version
printer friendly
pdf version
2007 U.S. Pharmacies & Drug Stores Industry Report
static version
printer friendly
pdf version
2007 Worldwide Drugs and Health and Beauty Aids Product Lines
static version
printer friendly
pdf version
2007 Worldwide Pharmaceutical Preparation Manufacturing Industry Report
static version
printer friendly
pdf version
2008 U.S. Drugs and Health and Beauty Aids Product Lines
static version
printer friendly
pdf version
2008 U.S. Medicinal & Botanical Manufacturing Industry Report
static version
printer friendly
pdf version
2008 U.S. Pharmaceutical Preparation Mfg. Industry Report
static version
printer friendly
pdf version
2008 U.S. Pharmacies & Drug Stores Industry Report
static version
printer friendly
pdf version
2008 Worldwide Drugs and Health and Beauty Aids Product Lines
static version
printer friendly
pdf version
2008 Worldwide Pharmaceutical Preparation Mfg. Industry Report
static version
printer friendly
pdf version
2008 Worldwide Pharmacies & Drug Stores Industry Report
static version
printer friendly
pdf version
21 Century Strategy of Pharmaceutical Manufacturers 2002 - Japan
static version
printer friendly
pdf version
25+ Business Development and Innovation Opportunities in Diabetes and Related Conditions - Emerging Opportunities to 2010
static version
printer friendly
pdf version
3-Volume Worldwide Pharmaceutical Regulation Series (2002)
static version
printer friendly
pdf version
4-Book Set of the 2003 Pocket-Sized CFR Reference Guides
static version
printer friendly
pdf version
42nd ICAAC 2002 - Biodefense and Emerging Infections
static version
printer friendly
pdf version
5-HT7 antagonists: Novel molecules for the unmet migraine prophylaxis market
static version
printer friendly
pdf version
^ Top
A
A Guide to Biosimilars, Biogenerics and Follow-On Biologics
static version
printer friendly
pdf version
A Guide to European Union Pharmaceutical Regulations
static version
printer friendly
pdf version
A Guide to Fixation and Preservation of Tissues
static version
printer friendly
pdf version
A Guide to Good Manufacturing Practices, 3rd Edition
static version
printer friendly
pdf version
A Guide to Pharmaceuticals in the European Union (EU): The Impact of EU Enlargement
static version
printer friendly
pdf version
A Guide to Royalty Rates in Pharmaceutical Licensing Deals
static version
printer friendly
pdf version
A Guide To US Reimbursement For Drugs, Medical Devices, and Diagnostics
static version
printer friendly
pdf version
A New Wave of IntraBiotech Alliances: A Company and Therapeutic Market Analysis
static version
printer friendly
pdf version
A Practical Guide to Biopharmaceutical Manufacturing
static version
printer friendly
pdf version
A Survey of ADME-TOX Trends in Drug Development
static version
printer friendly
pdf version
Abbott Laboratories
static version
printer friendly
pdf version
Abbott Laboratories Deals Briefing
static version
printer friendly
pdf version
Acid Related Gastrointestinal Disorders
static version
printer friendly
pdf version
Acute Myeloid Leukemia: Cytarabine Here to Stay
static version
printer friendly
pdf version
Addressing Key Challenges in Drug Safety (Strategic Focus)
static version
printer friendly
pdf version
Addressing Patient Compliance: Targeted marketing driving a shift in focus from acquisition to retention
static version
printer friendly
pdf version
Addressing Pharma’s R&D Productivity Crisis: Technological and Strategic Initiatives to Improve Core Drug Discovery Capabilities
static version
printer friendly
pdf version
ADME in Children and The Elderly: Clinical Challenges and Opportunities
static version
printer friendly
pdf version
Advanced Life Sciences Cethromycin - Phase III Success Should Allow Me-too Market Entry and Above-consensus Growth
static version
printer friendly
pdf version
Advanced Technologies for Optical Networks
static version
printer friendly
pdf version
Advances Imminent in Anti-Angiogenesis Therapeutic
static version
printer friendly
pdf version
Advances in Clinical Information Systems--An Impact Analysis
static version
printer friendly
pdf version
Advances in Glasses and Glass-Ceramics
static version
printer friendly
pdf version
Advances in Lab-on-Chip and Microfluidics Technologies for Drug Discovery and Clinical Diagnostics
static version
printer friendly
pdf version
Advances in the Treatment of Serious Systemic Fungal Infections--An Update
static version
printer friendly
pdf version
Advancing Drug Discovery Through Structure-Guided Drug Design
static version
printer friendly
pdf version
Advertising medicines and providing health information on the Internet
static version
printer friendly
pdf version
Airline-related VTE - A Flight of Ideas
static version
printer friendly
pdf version
Akzo Nobel Deals Briefing
static version
printer friendly
pdf version
Alcohol/Substance Abuse & Dependency; Evaluation and Management 2nd Edition - 2007 Update
static version
printer friendly
pdf version
Alcon Inc Deals Briefing
static version
printer friendly
pdf version
Alcon: Performance, Products, Pipeline and Potential
static version
printer friendly
pdf version
All Change in the US Pharma Market?
static version
printer friendly
pdf version
Allergan Inc Deals Briefing
static version
printer friendly
pdf version
Altana AG Deals Briefing
static version
printer friendly
pdf version
Alzheimers Disease - Beta Treatments On The Horizon
static version
printer friendly
pdf version
American Republic Insurance Business Intelligence Report
static version
printer friendly
pdf version
AmerisourceBergen Business Intelligence Report
static version
printer friendly
pdf version
Amgen Inc Deals Briefing
static version
printer friendly
pdf version
Amgen Incorporation: Corporate Analysis
static version
printer friendly
pdf version
Amgen: Performance, Products, Pipeline and Potential
static version
printer friendly
pdf version
Aminoglycoside Antibiotics: From Chemical Biology to Drug Discovery
static version
printer friendly
pdf version
Amyotrophic Lateral Sclerosis: Strategies for Drug Developers
static version
printer friendly
pdf version
An Industry in Crisis: Desperately Seeking New Strategies
static version
printer friendly
pdf version
An Industry in Crisis: Fixing Pharmas Damaged Reputation
static version
printer friendly
pdf version
Analgesics in Australia
static version
printer friendly
pdf version
Analgesics in Colombia
static version
printer friendly
pdf version
Analgesics in Finland
static version
printer friendly
pdf version
Analgesics in Ireland
static version
printer friendly
pdf version
Analgesics in Japan
static version
printer friendly
pdf version
Analgesics in Norway
static version
printer friendly
pdf version
Analgesics in Poland
static version
printer friendly
pdf version
Analgesics in Sweden
static version
printer friendly
pdf version
Analgesics in Thailand
static version
printer friendly
pdf version
Analgesics in the US
static version
printer friendly
pdf version
Analgesics in Turkey
static version
printer friendly
pdf version
Analysis of China Anti-impotence Drug Market
static version
printer friendly
pdf version
Analysis of Chinas Anti-impotence Drug Market
static version
printer friendly
pdf version
Analysis of Competitive Strategy for the Japanese Pharmas - Japan
static version
printer friendly
pdf version
Analysis of Levofloxacin Market
static version
printer friendly
pdf version
Analysis of Novo Nordisk
static version
printer friendly
pdf version
Analysis of the Chinese New Chemical Material Industry
static version
printer friendly
pdf version
Analysis of the Levofloxacin Market
static version
printer friendly
pdf version
Analysis of the Pharmaceutical Market to 2012 - Segmented by Drug Target Family
static version
printer friendly
pdf version
Analysis of Top 10 Specialty Pharmaceutical Companies
static version
printer friendly
pdf version
Analysis on Anti-cold Medicines in Recent Three Years
static version
printer friendly
pdf version
Analysis on Chinese Anti-Depression Medicine Market and the Brief Analysis on the Global Market
static version
printer friendly
pdf version
Analysis on the Chinese Anti-Depression Medicine Market and the Brief Analysis on the Global Market
static version
printer friendly
pdf version
Analysis Report of China Anti-HIV Drug Market
static version
printer friendly
pdf version
Analysis Report of China’s Anti-rheum Drug Market
static version
printer friendly
pdf version
Analysis Report of Chinas Anti-HIV Drug Market
static version
printer friendly
pdf version
Analysis Report on Anti-Gastrohelcosis Medicine Market in China
static version
printer friendly
pdf version
Analysis Report on China Antibiotic Industry
static version
printer friendly
pdf version
Analysis Report on China’s Anti-Tumor Medicine Market
static version
printer friendly
pdf version
Analysis Report on China’s Antibiotic Market
static version
printer friendly
pdf version
Analysis Report on China’s Antineoplastic Market
static version
printer friendly
pdf version
Analysis Report on China’s Ferrous Sulphate & Anti-anemia Medicine Market
static version
printer friendly
pdf version
Analysis Report on China’s HBV Medicine Market
static version
printer friendly
pdf version
Analysis report on China’s Insulin Market
static version
printer friendly
pdf version
Analysis Report on China’s Insulin Market
static version
printer friendly
pdf version
Analysis Report on China’s Market of Gynecological External Preparations
static version
printer friendly
pdf version
Analysis Report on China’s Metformin & Diabetes Medicine Market
static version
printer friendly
pdf version
Analysis Report on China’s Oral Diabetes Drug Market
static version
printer friendly
pdf version
Analysis Report on China’s Pediatric Medicine Market
static version
printer friendly
pdf version
Analysis Report on China’s Slimming Drug Market
static version
printer friendly
pdf version
Analysis Report on China’s Slimming Drug Market
static version
printer friendly
pdf version
Analysis Report on China’s Spore Class Antibiotic Market
static version
printer friendly
pdf version
Analysis Report on Chinese Anti-Epiphyte Medicine Market
static version
printer friendly
pdf version
Analysis Report on Chinese Anti-Virus Medicine Market
static version
printer friendly
pdf version
Analysis Report on Chinese Medicine Retailing Market
static version
printer friendly
pdf version
Analysis Report on the Blood Fat Capitulating Medicine Market in China
static version
printer friendly
pdf version
Analysis Report on the Chinese Anti-Epiphyte Medicine Market
static version
printer friendly
pdf version
Analysis Report on the Chinese Anti-Virus Medicine Market
static version
printer friendly
pdf version
Analysis Report on the Chinese Medicine Retailing Market
static version
printer friendly
pdf version
Analysis Report on the Key Enterprises of VC Manufacturers in China
static version
printer friendly
pdf version
Analytical Method Validation and Instrument Performance Verification
static version
printer friendly
pdf version
Analytical Tool - Analysis of Cancer Immunotherapy: The World Guide
static version
printer friendly
pdf version
Analytical Tool - Breast Cancer Therapeutics & Competitive Insights
static version
printer friendly
pdf version
Analytical Tool - Competitive Outlook on Anti-Angiogenesis and Vascular Targeting in Oncology
static version
printer friendly
pdf version
Analytical Tool - Competitive Outlook on Cancer Vaccines
static version
printer friendly
pdf version
Analytical Tool - Hematological Cancers
static version
printer friendly
pdf version
Analytical Tool - Lymphoma Therapeutics & Competitive Insights
static version
printer friendly
pdf version
Analytical Tool - Targeted Therapeutics: Non-Small Cell Lung Cancer
static version
printer friendly
pdf version
Analytical Tool - The Commercial Success of Cancer Therapeutic Antibodies
static version
printer friendly
pdf version
Analytical Tool: Competitive Outlook on HCV
static version
printer friendly
pdf version
Analyzing the Generic Drugs Sector of the US Pharmaceutical Industry
static version
printer friendly
pdf version
Analyzing the Global Pharmaceutical Industry
static version
printer friendly
pdf version
Analyzing the Indian Pharmaceutical Industry
static version
printer friendly
pdf version
Analyzing the Major Pharmaceutical Markets
static version
printer friendly
pdf version
Andrx Corporation Business Intelligence Report
static version
printer friendly
pdf version
Anesthesia Competitors
static version
printer friendly
pdf version
Angiogenesis Inhibitors and Stimulators - Global Strategic Business Report
static version
printer friendly
pdf version
Angiogenesis Inhibitors: An Update - Can Iressa and Thalomid Rejuvenate the Angiogenesis Inhibitor Class?
static version
printer friendly
pdf version
Annual Change in Global Pharmaceutical R&D Spending, 1998-2002
static version
printer friendly
pdf version
Annual Numbers of New Chemical Entities Approved in Japan, 1983-2003
static version
printer friendly
pdf version
Antibacterial Drug Resistance: Expanding Opportunities in the Hospital Market
static version
printer friendly
pdf version
Antibacterials - Pharma Strikes Antibac
static version
printer friendly
pdf version
Antibiotics - Global Strategic Business Report
static version
printer friendly
pdf version
Antibodies In China
static version
printer friendly
pdf version
Antibody Drug Target Atlas in Oncology
static version
printer friendly
pdf version
Antibody Engineering: Technologies, Applications, and Business Opportunities
static version
printer friendly
pdf version
Antibody Technology Developments (Technical Insights)
static version
printer friendly
pdf version
Antibody Therapeutics: Product Development, Market Trends, and Strategic Issues, Revised Edition
static version
printer friendly
pdf version
Antibody Therapeutics: Production, Clinical Trials, and Strategic Issues
static version
printer friendly
pdf version
Anticoagulants - Global Strategic Business Report
static version
printer friendly
pdf version
Antidepressants - Global Strategic Business Report
static version
printer friendly
pdf version
Antifungals: 2004 and Beyond
static version
printer friendly
pdf version
Antihypertensives - Two Years to Shape the Market?
static version
printer friendly
pdf version
Antihypertensives - Weak Pipeline Leaves Innovation to Novartis
static version
printer friendly
pdf version
Antimicrobial resistance: Resistance drives a mature
static version
printer friendly
pdf version
Antiviral Drugs
static version
printer friendly
pdf version
Antiviral HIV Treatment in Developing Countries Number of Patients
static version
printer friendly
pdf version
Antiviral Therapeutics - technologies, markets and companies
static version
printer friendly
pdf version
Antivirals - Global Strategic Business Report
static version
printer friendly
pdf version
Anxiety Disorders - A Decade of Declining Revenues
static version
printer friendly
pdf version
Anxiety Disorders: The New Focus for Antidepressants
static version
printer friendly
pdf version
Apoptosis 2008
static version
printer friendly
pdf version
Applications of Stem Cells in Drug Discovery
static version
printer friendly
pdf version
Aquaculture & Fisheries - Global Strategic Business Report
static version
printer friendly
pdf version
Aquaculture- Global Technology Developments
static version
printer friendly
pdf version
ARDS: Searching for Effective Therapies
static version
printer friendly
pdf version
Argentina - Pharmaceutical Industry Overview
static version
printer friendly
pdf version
Argentina Pharmaceuticals and Healthcare Report Q1 2008
static version
printer friendly
pdf version
Argentina Pharmaceuticals and Healthcare Report Q2 2008
static version
printer friendly
pdf version
Argentina Pharmaceuticals and Healthcare Report Q3 2007
static version
printer friendly
pdf version
Arthritis in the United States
static version
printer friendly
pdf version
Asia Pacific Markets for Facial Aesthetics
static version
printer friendly
pdf version
Asia Pacific Markets for Incontinence Devices
static version
printer friendly
pdf version
Asia-Pacific Nutraceuticals
static version
printer friendly
pdf version
Asia-Pacific Nutraceuticals
static version
printer friendly
pdf version
Asia-Pacific Pharmaceuticals
static version
printer friendly
pdf version
Asia: Threat or Opportunity?
static version
printer friendly
pdf version
Aspirin Production & Market in China
static version
printer friendly
pdf version
Astellas Pharma Inc Deals Briefings
static version
printer friendly
pdf version
Astellas Pharma: Performance, Products, Pipeline and Potential
static version
printer friendly
pdf version
Asthma and COPD Drug Discoveries: What the Future Holds
static version
printer friendly
pdf version
AstraZeneca Deals Briefing
static version
printer friendly
pdf version
AstraZeneca: PharmaVitae Profile 2005
static version
printer friendly
pdf version
Atopic Dermatitis: Generic Erosion Leads to Stagnant Market
static version
printer friendly
pdf version
Atrial Fibrillation: Emerging Drug Discovery Targets and Therapeutic Candidates
static version
printer friendly
pdf version
Attitudes Towards Health & Pharmaceuticals in the United States
static version
printer friendly
pdf version
Atypical Antipsychotics: Life-Cycle Management and Future Trends
static version
printer friendly
pdf version
Australia Pharmaceuticals & Healthcare Report Q1 2008
static version
printer friendly
pdf version
Australia Pharmaceuticals and Healthcare Report Q2 2008
static version
printer friendly
pdf version
Australia Pharmaceuticals and Healthcare Report Q3 2007
static version
printer friendly
pdf version
Australian Drug Industry
static version
printer friendly
pdf version
Australian Pharmaceutical Industry
static version
printer friendly
pdf version
Autoimmune Market Outlook to 2012
static version
printer friendly
pdf version
Automation and Control Solutions in the European Pharmaceutical Market
static version
printer friendly
pdf version
Average Annual Drug Spending as a Percentage of Household Spending, 1996-2008
static version
printer friendly
pdf version
Average Year of Year Change in Prices of Drugs and Medical Supplies, 2000-2004
static version
printer friendly
pdf version
Avian Influenza: The Threatening Pandemic
static version
printer friendly
pdf version
^ Top
B
Bahrain Pharmaceuticals & Healthcare Report Q1 2008
static version
printer friendly
pdf version
Bahrain Pharmaceuticals and Healthcare Report Q3 2007
static version
printer friendly
pdf version
Barr Pharmaceuticals Busintell Report
static version
printer friendly
pdf version
Barr Pharmaceuticals Inc Deals Briefing
static version
printer friendly
pdf version
Barriers to Effective Management of Metabolic Syndrome
static version
printer friendly
pdf version
Basic Platform Report: Cancer Vaccines
static version
printer friendly
pdf version
Baxter International Inc Deals Briefing
static version